Rindos Noah, Curry Christine L, Tabbarah Rami, Wright Valena
Department of Obstetrics and Gynecology, Boston University Medical Center, 85 E Concord St, Boston, MA 02118, USA.
Department of Obstetrics and Gynecology, Boston University Medical Center, Boston, MA, USA.
JSLS. 2014 Jan-Mar;18(1):66-70. doi: 10.4293/108680813X13693422519271.
Robotic-assisted laparoscopic surgery is increasingly used for the management of patients with gynecologic malignancies. The rate of portsite metastases in patients undergoing these procedures is unknown.
We conducted a retrospective cohort analysis of a prospective database. A total of 220 women underwent robotic-assisted surgery from 2007 through 2011. Malignancy was detected in 145 cases, and 142 met the inclusion criteria with histologically proven cancer and robotically completed surgery. All women who underwent surgical treatment for their malignancies were followed up at the study site for oncology treatments.
There were 710 potential port sites for metastasis. We found that 2 of 142 patients each had a single port-site metastasis, for an overall rate of 1.41%, or 0.28% per trocar site. Recurrent disease was not isolated in the two patients found to have port-site metastases because both had concurrent sites of pelvic recurrence.
The rate of port-site metastases in patients undergoing robotic-assisted laparoscopic surgery for gynecologic malignancies is similar to the published rate in the literature for traditional laparoscopic oncology.
机器人辅助腹腔镜手术越来越多地用于妇科恶性肿瘤患者的治疗。接受这些手术的患者的穿刺口转移率尚不清楚。
我们对一个前瞻性数据库进行了回顾性队列分析。2007年至2011年期间，共有220名女性接受了机器人辅助手术。145例检测到恶性肿瘤，142例符合纳入标准，经组织学证实为癌症且手术由机器人完成。所有接受恶性肿瘤手术治疗的女性均在研究地点接受肿瘤治疗随访。
共有710个可能发生转移的穿刺口。我们发现，142例患者中有2例各有一处穿刺口转移，总体发生率为1.41%，即每个套管针穿刺口的发生率为0.28%。在发现有穿刺口转移的两名患者中，复发疾病并非仅局限于穿刺口，因为两人同时都有盆腔复发部位。
接受机器人辅助腹腔镜手术治疗妇科恶性肿瘤的患者的穿刺口转移率与传统腹腔镜肿瘤手术文献中公布的发生率相似。
